AGLE - Aeglea BioTherapeutics GAAP EPS of -$0.20 misses by $0.03 revenue of $0.2M beats by $0.12M May, 11 2023 09:42 AM Aeglea BioTherapeutics Inc. 2023-05-11 09:42:16 ET Aeglea BioTherapeutics press release ( NASDAQ: AGLE ): Q1 GAAP EPS of -$0.20 misses by $0.03 . Revenue of $0.2M (-85.3% Y/Y) beats by $0.12M . For further details see: Aeglea BioTherapeutics GAAP EPS of -$0.20 misses by $0.03, revenue of $0.2M beats by $0.12M